NEWS & EVENTS

Catalent today announced that Greg Bleck, Ph.D., Global Head of R&D, Catalent Biologics will present at the upcoming annual PEGS Europe conference, which will be held at the Lisboa Congress Center, Lisbon, Portugal, on Nov. 18 – 22, 2019.

Catalent today announced that its Chair and Chief Executive Officer, John Chiminski, has received the inaugural CPhI Pharma Awards ‘Lifetime Achievement Award’ at CPhI Worldwide.

Catalent today announced it will present at the upcoming World Orphan Drug Congress Europe, being held at Hotel Sofia, Barcelona, Spain on Nov. 12 – 14, 2019.

Catalent, today announced the launch of its next-generation cell line development technology, GPEx® Boost.

Catalent (stand 121A82) today announced a busy conference program at the forthcoming CPhI Worldwide annual conference, being held at the Messe Frankfurt, Frankfurt, Germany, on Nov. 5 – 7, 2019.

Catalent today announced it will give two presentations during the “Manufacturing and Bioprocessing Track” at the forthcoming American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 at the Henry B. Gonzalez Convention Center, San Antonio, Texas, on Nov. 3 – 6, 2019.

Catalent today announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and Personal Care Logistics Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28 – 30, 2019.

Catalent today announced that Mark Woolf, its Director of Depot Networks, will present at the upcoming 6th Annual Global Clinical Supplies Group European Knowledge Forum, to be held in Cascais, Portugal, on Oct. 22 – 24, 2019.

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that it will present at the upcoming SupplySide West conference in Las Vegas.